These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Adsorption of lipid liquid crystalline nanoparticles: effects of particle composition, internal structure, and phase behavior. Chang DP; Jankunec M; Barauskas J; Tiberg F; Nylander T Langmuir; 2012 Jul; 28(29):10688-96. PubMed ID: 22725977 [TBL] [Abstract][Full Text] [Related]
3. The lipolytic degradation of highly structured cubic micellar nanoparticles of soy phosphatidylcholine and glycerol dioleate by phospholipase A Wadsäter M; Barauskas J; Tiberg F; Nylander T Chem Phys Lipids; 2018 Mar; 211():86-92. PubMed ID: 29132829 [TBL] [Abstract][Full Text] [Related]
4. Structural effects of the dispersing agent polysorbate 80 on liquid crystalline nanoparticles of soy phosphatidylcholine and glycerol dioleate. Wadsäter M; Barauskas J; Rogers S; Skoda MW; Thomas RK; Tiberg F; Nylander T Soft Matter; 2015 Feb; 11(6):1140-50. PubMed ID: 25531822 [TBL] [Abstract][Full Text] [Related]
5. Formation of highly structured cubic micellar lipid nanoparticles of soy phosphatidylcholine and glycerol dioleate and their degradation by triacylglycerol lipase. Wadsäter M; Barauskas J; Nylander T; Tiberg F ACS Appl Mater Interfaces; 2014 May; 6(10):7063-9. PubMed ID: 24779728 [TBL] [Abstract][Full Text] [Related]
6. Interactions of lipid-based liquid crystalline nanoparticles with model and cell membranes. Barauskas J; Cervin C; Jankunec M; Spandyreva M; Ribokaite K; Tiberg F; Johnsson M Int J Pharm; 2010 May; 391(1-2):284-91. PubMed ID: 20214966 [TBL] [Abstract][Full Text] [Related]
7. Lipid-based liquid crystalline nanoparticles as oral drug delivery vehicles for poorly water-soluble drugs: cellular interaction and in vivo absorption. Zeng N; Gao X; Hu Q; Song Q; Xia H; Liu Z; Gu G; Jiang M; Pang Z; Chen H; Chen J; Fang L Int J Nanomedicine; 2012; 7():3703-18. PubMed ID: 22888230 [TBL] [Abstract][Full Text] [Related]
8. Characterization of a Liquid Crystal System for Sustained Release of a Peptide BMS-686117. Xu Y; Li V; Li J; Pan D; Langenbucher G; Mathias N AAPS PharmSciTech; 2018 Jan; 19(1):348-357. PubMed ID: 28741139 [TBL] [Abstract][Full Text] [Related]
9. Bioadhesive lipid compositions: self-assembly structures, functionality, and medical applications. Barauskas J; Christerson L; Wadsäter M; Lindström F; Lindqvist AK; Tiberg F Mol Pharm; 2014 Mar; 11(3):895-903. PubMed ID: 24422996 [TBL] [Abstract][Full Text] [Related]
10. Interaction between lamellar (vesicles) and nonlamellar lipid liquid-crystalline nanoparticles as studied by time-resolved small-angle X-ray diffraction. Vandoolaeghe P; Barauskas J; Johnsson M; Tiberg F; Nylander T Langmuir; 2009 Apr; 25(7):3999-4008. PubMed ID: 19714888 [TBL] [Abstract][Full Text] [Related]
11. Freeze-dried and re-hydrated liquid crystalline nanoparticles stabilized with disaccharides for drug-delivery of the plectasin derivative AP114 antimicrobial peptide. Boge L; Västberg A; Umerska A; Bysell H; Eriksson J; Edwards K; Millqvist-Fureby A; Andersson M J Colloid Interface Sci; 2018 Jul; 522():126-135. PubMed ID: 29587194 [TBL] [Abstract][Full Text] [Related]
12. Incorporation of quercetin in lipid microparticles: effect on photo- and chemical-stability. Scalia S; Mezzena M J Pharm Biomed Anal; 2009 Jan; 49(1):90-4. PubMed ID: 19042102 [TBL] [Abstract][Full Text] [Related]
13. Adsorption of lipid liquid crystalline nanoparticles on cationic, hydrophilic, and hydrophobic surfaces. Chang DP; Jankunec M; Barauskas J; Tiberg F; Nylander T ACS Appl Mater Interfaces; 2012 May; 4(5):2643-51. PubMed ID: 22515950 [TBL] [Abstract][Full Text] [Related]